News

Home / News

Announcement on behalf of major subsidiary,CHUANG YI BIOTECH CO.,LTD.,regarding acquisition of right-of-use asset from related

2024.12.27

1.Date of occurrence of the event:2024/12/27

2.Date of the original announcement and reporting:2024/10/01

3.Summary of the content originally announced and reported: Leased the Taipei office on 3F-1,No.3-1,Park St.,Nangang Dist., Taipei City,Taiwan(R.O.C.), from the Parent Company of the Company, TSH Biopharm Corporation Limited. The contents of the original lease information are as follows: Taipei office
Transaction unit amount:70 pings
Unit price:NT$1,398 per ping per month
Total monthly cost: NT$120,000 per month (including water, electricity, cleaning and management fees)
The lease period is from 2024/10/01-2025/12/31
Total right-of-use asset value: NT$1,776,608

4.Reason for change and its main content:
On 2024/12/27the board of directors approved the renewal of the original lease contract period and transaction amount, and the updated information is as follows: Taipei office
Transaction unit amount:70 pings
Unit price:NT$1,500 per ping per month
Total monthly cost: NT$127,140 per month (including water, electricity, cleaning and management fees)
The lease period is from 2025/01/01-2026/12/31
Total right-of-use asset value: NT$3,000,089

5.Effect on the Company’s finance and business after the change:NA

6.Any other matters that need to be specified:NA